% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • tradingexpert4me tradingexpert4me Feb 16, 2013 6:20 PM Flag

    Moral code, misleading info? RELAX dude, at the end of the day, either the science holds up, or it doesn't.


    That said, the science will determine the winners long, or short. You sound worried and perhaps you should be.

    Adam F. back his claim that Galena insiders were data mining, or as he actually put it, CHERRY PICKING.

    Let me ask you a question. How much DD have you actually done on Galena's CEO Ahn? Besides his over compensating himself at the annual tune of $1.2M, his background puts him clearly on the HOUSE OF SHAME as a CEO. Not to mention, Ahn has never really vested into any of the companies he's been involved with, to include Galena. Sure he has a few shares, but nothing worth consideration, or real skin in the game.

    NeuVax most recent data was questionable and made very clear by Adam F. However, data mining or cherry picking if you prefer, isn't very difficult to get away with until you enter PHASE III. The questionable data to date, is clearly the reason this companies stock continues to remain under $2.00 per share.

    Furthermore, does it bother anyone here, that CEO Ahn still has not updated shareholders with the PHASE III patient enrollment, or cost of same to include projected costs once fully enrolled. Sure bothers me.

    BOTTOM LINE: PHASE III interim data later this year, is going to make, or break this company, so Ahn better have the goods and those goods better not be questionable at all, or game over.


    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.01-0.09(-4.29%)Jun 27 4:00 PMEDT